Advertisement

Topics

NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care Company Profile

04:12 EDT 25th June 2018 | BioPortfolio

NovaBay Pharmaceuticals is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX™ Family of Products, including AVENOVA™ for the eye care market and NEUTROPHASE® for wound care, which was initially cleared by the FDA, and CELLERX™ for the dermatology market; and its AGANOCIDE® compounds, led by AURICLOSENE™. NovaBay is partnered in the U.S. and around the globe with: PBE, Inc. (USA), IHT, Inc. (USA), Galderma (France), Virbac (France), China Pioneer Pharma (China and Southeast Asia), Shin Poong Pharmaceuticals (South Korea), Biopharm (North Africa and Middle East), Sarmedic Ltd (Israel) and Alpha Pharma LLC (Ukraine).


News Articles [1451 Associated News Articles listed on BioPortfolio]

Moving forward: NovaBay's present and future plans for its compounds

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Ron Najafi, Chief Executive Officer at NovaBay Pharmaceuticals, a product development firm targeting infections in ...

NovaBay Pharmaceuticals to Hold First Quarter 2018 Conference Call on May 10, 2018

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for t...

NovaBay Pharmaceuticals to Hold 2017 Fourth Quarter and Full Year Conference Call on March 20, 2018

NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing its prescription Avenova® lid and lash hygiene product for th...

NovaBay gets $6mm via PIPE

NovaBay Pharmaceuticals Inc. (developed Avenova for lid and lash hygiene, NeutroPhase skin and wound cleanser, and CelleRx for aesthetic dermatology) grossed $6mm through the private placement of 1.7m...

Will PHOENIX Make RETA Fly?

Reata Pharmaceuticals Inc. (RETA) has reported positive interim data from its phase II study, dubbed PHOENIX.

NovaBay Pharmaceuticals' (NBY) CEO Mark Sieczkarek on Q4 2017 Results - Earnings Call Transcript

NovaBay Pharmaceuticals' (NBY) CEO Mark Sieczkarek on Q1 2018 Results - Earnings Call Transcript

NovaBay Raises $6 Million from Hong Kong's OP Financial

NovaBay® Pharma, a Bay-area anti-microbial company, announced a new private placement of $6 million from OP Financial, a Hong Kong-listed investor. The transaction replaces one, announced two mont...

PubMed Articles [3984 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Induction of apoptosis and cell cycle arrest by ethyl acetate fraction of Phoenix dactylifera L. (Ajwa dates) in prostate cancer cells.

Phoenix dactylifera L. (Ajwa date) has high nutritive value and are consumed in Arabian Peninsula as an essential diet. Phoenix dactylifera L. have been mentioned in folk remedies of traditional Egypt...

Abstracts from Center to Advance Palliative Care National Seminar Practical Tools for Making Change November 9-11, 2017 Phoenix, Arizona.

Comparison of tigecycline susceptibility testing methods for multidrug-resistant Acinetobacter baumannii.

Automated systems Vitek 2, BD Phoenix, MicroScan WalkAway and gradient diffusion assays Etest and MIC Test Strip were compared against broth microdilution for susceptibility testing of tigecycline aga...

Photodegradation of pharmaceuticals and personal care products in water treatment using carbonaceous-TiO composites: A critical review of recent literature.

The high concentrations of pharmaceuticals and personal care products (PPCP) that found in water in many locations are of concern. Among the available water treatment methods, heterogeneous photocatal...

Clinical Trials [4125 Associated Clinical Trials listed on BioPortfolio]

Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems

The Phoenix Post-Approval Registry is a prospective, multi-center, single arm registry sponsored by Volcano Corporation to evaluate the short and long term performance and clinical outcome...

Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora

This study is designed to evaluate the effect of Novabay iLid Cleanser, as compared to its Vehicle, on the ocular skin flora. In the pre-randomization phase, subjects will receive a singl...

SWORD Phoenix Versus Standard of Care in the Rehabilitation After Total Hip Replacement

The study was designed to evaluate the effectiveness of a novel kinematic biofeedback system - SWORD Phoenix- in the rehabilitation after total hip replacement . SWORD Phoenix allows the p...

SWORD Phoenix Versus Standard of Care in the Rehabilitation After Total Knee Replacement

The study was designed to evaluate the effectiveness of a novel kinematic biofeedback system - SWORD Phoenix- in the rehabilitation after total knee replacement . SWORD Phoenix allows the...

Low-level Laser Therapy in Patients With Chronic Fibromyalgia

The purpose of this study is to examine the use of low level therapeutic laser (LLLT) for its effects on pain, fatigue, and physical function in individuals with fibromyalgia.

Companies [3405 Associated Companies listed on BioPortfolio]

NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care

NovaBay Pharmaceuticals is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs...

NovaBay Pharmaceuticals, Inc.:

NovaBay Pharmaceuticals is a biopharmaceutical company focusing on the commercialization of prescription Avenova® Lid and Lash Cleanser for the eye care market. Avenova is form...

NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals is a biopharmaceutical company focusing commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of...

NovaBay Pharmaceuticals, Inc.

ANTI-INFECTIVE COMPOUNDS EFFECTIVE AGAINST BACTERIA, VIRUSES AND FUNGI NovaBay Pharmaceuticals is a clinical-stage biotechnology company focused on developing its proprietary and patented Aganocide...

Phoenix Healthcare Intelligence, LLC

Phoenix Healthcare Intelligence, LLC ("Phoenix") is a healthcare information technology company that supplies an enterprise-wide decision support software tool designed for clinical and business users...

More Information about "NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care" on BioPortfolio

We have published hundreds of NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care news stories on BioPortfolio along with dozens of NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care Clinical Trials and PubMed Articles about NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care Companies in our database. You can also find out about relevant NovaBay Pharmaceuticals, Inc. and Phoenix Eye Care Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record